Gentex reported consolidated net sales of $644.4 million in Q4 2025, up 19% from $541.6 million in Q4 2024. Excluding VOXX (acquired April 1, 2025), core Gentex sales were $541.0 million, essentially flat year-over-year despite a 2% decline in light-vehicle production in key markets. Consolidated net income attributable to Gentex was $93.0 million, or $0.43 per diluted share, compared with $87.7 million, or $0.39 per share, in the year-ago quarter. VOXX contributed $103.4 million of Q4 revenue, reflecting strong seasonal demand that bolstered overall performance.

Gross margin for the quarter expanded to 34.8% on a consolidated basis and 35.5% on a core Gentex basis, a 300 basis-point improvement over Q4 2024. Management attributed the gain to favorable product mix, operational efficiencies and purchasing cost reductions, partly offset by tariff-related costs that reduced margin by roughly 150 basis points net of recoveries. Operating expenses totaled $104.4 million consolidated, with core Gentex expenses at $79.8 million, down from $86.5 million in Q4 2024 after excluding a one-time goodwill impairment. As a result, core income from operations rose 25.3% year-over-year to $112.5 million.

For the full calendar year 2025, consolidated net sales reached $2.53 billion, a 10% increase over 2024, while core Gentex sales of $2.27 billion declined 2% due to tariff impacts on China exports. Full-year consolidated gross margin improved to 34.2%, with core margin at 34.7%, up 140 basis points despite lower sales. Operating income was $473.9 million, and net income attributable to Gentex totaled $384.8 million, or $1.74 per diluted share. The company returned $425.9 million to shareholders, deploying $319.0 million in share repurchases (13.6 million shares) and $106.9 million in dividends, a 35% increase in capital returned versus 2024.